Miriam Provost - 30 Jul 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP of US Regulatory & FDA Rel.
Signature: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 30 Jul 2021
Net transactions value: +$7,103
Form type: 4
Filing time: 03 Aug 2021, 17:00:35 UTC
Next filing: 17 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$7,103	+2,206	+48%	$3.22^*	6,806	30 Jul 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-2,206	-9.2%	$0.000000	21,765	30 Jul 2021	Common Stock	2,206	$3.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date.